TrendingVideosIndia
Opinions ▾
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
UPSC ▾
UPSC | Exam ScheduleExam Mentor
State ▾
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City ▾
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World ▾
World | ChinaUnited StatesPakistan
Diaspora
Features ▾
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business ▾
Business | My MoneyAutoZone
News Columns ▾
News Columns | Straight DriveCanada CallingLondon LetterKashmir AngleJammu JournalInside the CapitalHimachal CallingHill View
Don't Miss
Advertisement
Home / Nation / Us Ignored Concerns Over Hcq From India 81428

US ‘ignored’ concerns over HCQ from India

Fired expert alleges drug supplies came from ‘uninspected’ Indian, Pak factories
Tribune News Service
Updated At : 01:12 PM May 07, 2020 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

Washington, May 6

Advertisement

A fired American vaccine expert has alleged that the Trump administration ignored the concerns of doctors over the import of hydroxychloroquine from “uninspected” factories in India and Pakistan and flooded the US with the unproven and potentially dangerous anti-malarial drug to treat coronavirus patients.

Advertisement

Dr Rick Bright led the Biomedical Advanced Research and Development Authority, a US government agency, which is trying to develop a vaccine for the deadly coronavirus that has claimed over 71,000 lives and infected over 1.2 million people in America, the worst hit nation.

In a plaint filed before the US Office of Special Counsel, which oversees the protection of whistleblowers, the scientist said he was ousted for questioning potential of hydroxychloroquine (HCQ), touted by President Donald Trump as a game changer. — PTI

Advertisement
Advertisement

Suggested Articles

Show comments
Advertisement
Advertisement

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Copyright © The Tribune Trust, 2024
Designed and developed by :  SORTD